Topic:

Cancer

Latest Headlines

Latest Headlines

Myriad settles patent feud with Invitae, Pathway Genomics over BRCA technology

Myriad Genetics is throwing in the towel in its fight to stop other companies from offering diagnostic tests that spot specific genes known to be associated with a higher risk of breast cancer.

Singapore to detail trial of MicroVAX novel cancer vaccine

The National Cancer Centre Singapore will brief on the status of a first-in-human clinical trial using an adenovirus under a protocol endorsed by the U.S. Food and Drug Administration and Singapore's Health Sciences Authority, highlighting the wealthy city-state's push to be a leader in early stage clinical trials in Asia.

Biocept joins up with Insight Genetics for lung cancer test

San Diego-based oncology diagnostics outfit Biocept is teaming up with Insight Genetics of Nashville to develop an improved diagnostic for the most common type of lung cancer.

Cancer Genetics gets nod to offer cancer testing in California

Cancer Genetics got a green light from the California Department of Health to provide its oncology testing services for patients in the state, a big win that could help the company churn out a profit in the coming year.

Brown U dean points to a possible suspect driving metastasis

Dr. Jack Elias, dean of medicine and biological sciences at Brown University, has been studying the role of a protein called chitinase 3-like-1 in fibrosis and asthma for years. And now he says that new animal research indicates that this could also be a good target for cancer metastasis.

Myriad loses a battle in BRCA patent war

Diagnostics giant Myriad Genetics suffered a stinging setback in its ongoing battle to keep rival breast cancer DNA tests off the market, as a U.S. appeals court ruled that its patents for the products are not eligible for legal protection.

Amgen vet reveals stealth startup Flexus backed by $38M from Kleiner Perkins, Celgene

After shunning public attention for more than a year, cancer immunotherapy startup Flexus Biosciences is ready for the limelight now that it is headed toward the clinic, has banked its first two venture rounds totaling $38 million and boasts impressive management, board and advisory rosters.

Invitae scores CMS and Blue Shield of California coverage for genetic tests

Genetic information outfit Invitae secured reimbursement for its testing services from Blue Shield of California and the Centers for Medicare and Medicaid Services, moving the company forward on its path toward domestic and international growth.

UC Irvine investigators feature a new class of 'chemosensitizers'

Scientists with the UC Irvine School of Medicine and the Italian Institute of Technology have spotlighted what they call the "very first class" of acid ceramidase inhibitors that could eventually go on to help amp up the effectiveness of chemotherapies.

UC Irvine investigators spotlight a new class of 'chemosensitizers'

Scientists with the UC Irvine School of Medicine and the Italian Institute of Technology have spotlighted what they call the "very first class" of acid ceramidase inhibitors that could eventually go on to help amp up the effectiveness of chemotherapies.